JFG
GOSS icon

Jefferies Financial Group’s Gossamer Bio GOSS Stock Holding History

Jefferies Financial Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,250
Closed -$110K – 1520
2025
Q1 		$110K Hold
1,250
– – ﹤0.01% 1459
2024
Q4 		$90.5K Buy
+1,250
New +$85.7K ﹤0.01% 1469
2024
Q2 		– Sell
-670
Closed -$63.2K – 1573
2024
Q1 		$63.2K Buy
+670
New +$59K ﹤0.01% 1479
2023
Q1 		– Sell
-1,250
Closed -$217K – 1755
2022
Q4 		$217K Buy
+1,250
New +$823K ﹤0.01% 1280

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Jefferies Financial Group's GOSS Position: Q2 2025 in Review

Jefferies Financial Group sold out of Gossamer Bio (GOSS) in Q2 2025, closing a stake of 1,250 shares — an estimated $110K sold.

Jefferies Financial Group first reported a position in GOSS in Q4 2022 and held it in 4 quarters. The position peaked at $217K in Q4 2022. 121 funds tracked by Wall St. Rank hold GOSS as of Q2 2025.

  • Jefferies Financial Group reported no remaining Gossamer Bio position as of Q2 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 1,250 Gossamer Bio shares in Q2 2025, an estimated $110K.
  • Jefferies Financial Group first reported a position in Gossamer Bio in Q4 2022 and held it in 4 quarters.
  • Jefferies Financial Group's Gossamer Bio position peaked at $217K in Q4 2022.
  • 121 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2025.

Based on Jefferies Financial Group's 13F filing for Q2 2025, filed 12 Aug 2025.